• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS ESHEATH+ INTRODUCER SET; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS ESHEATH+ INTRODUCER SET; INTRODUCER, CATHETER Back to Search Results
Model Number 916ESPA
Medical Device Problem Codes Detachment of Device or Device Component (2907); Material Split, Cut or Torn (4008)
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 02/04/2026
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
This is one of two manufacturer reports being submitted for this case.The investigation is ongoing.
 
Event or Problem Description
As reported by the field clinical specialist (fcs), during a transfemoral transcatheter aortic valve replacement (tavr) procedure using a 29 mm sapien 3 ultra resilia valve, there was slight difficulty encountered during the fine adjust portion of valve alignment.Valve alignment was attempted in a straight section of the anatomy.It was able to be resolved by unlocking and then re-locking.Subsequently, during valve deployment, there was non-uniform expansion of the valve.It was noted that while deploying the valve, the distal portion pointing towards the left ventricle (lv) opened significantly later than the proximal portion of the valve directed towards the aorta.The valve was reported to be between the markers before deployment.Ultimately, the valve deployed satisfactory.Post-deployment echocardiography showed the valve was fully expanded.The patient was transferred for recovery in stable condition.There was no patient injury.Per additional information received from the fcs, there was no damage observed on the delivery system and no damage observed on the esheath+.There was normal resistance during insertion of the delivery system with valve through the sheath.The inflation was intentionally slower and deflation was normal.The device was not torqued during the procedure.There were no difficulties withdrawing the delivery system and/or sheath.There was no fluid loss noticed.Imagery was received for evaluation.Per review of the procedural fluoroscopy imagery, the transcatheter heart valve (thv) appeared to be positioned between the valve alignment markers prior to deployment.The video shows approximately 10 seconds of inflation and ends before full inflation is reached.It does not show the full deployment cycle (inflation and deflation) time.The balloon inflated asymmetrically for approximately the first 7 seconds of inflation, with the distal end appearing constrained.The distal constraint was then overcome and the distal end of the thv began to expand.After the constraint was overcome, there appears to be a c-shaped shadow near the distal end, resembling a torn and separated sheath tip.
 
Additional Manufacturer Narrative
A supplemental report is being submitted for correction and to include additional information from the investigation.The following sections of this report have been corrected/updated: h6 (type of investigation, investigation findings, investigation conclusions) and h11 (additional narrative/data).The events reported are anticipated in the risk management documentation for transcatheter heart valve procedures.A previous investigation into this type of event is captured in an edwards lifesciences technical summary and applies to this complaint.Additional assessment of the failure modes is not required at this time.The device was not returned for evaluation as it was discarded.Due to the unavailability of the device, no visual inspection, functional testing, or dimensional analysis could be performed.There was imagery received for evaluation.Per review of the procedural fluoroscopy imagery, the transcatheter heart valve (thv) appeared to be positioned between the valve alignment markers prior to deployment.The video shows approximately 10 seconds of inflation and ends before full inflation is reached.It does not show the full deployment cycle (inflation and deflation) time.The balloon inflated asymmetrically for approximately the first 7 seconds of inflation, with the distal end appearing constrained.The distal constraint was then overcome and the distal end of the thv began to expand.After the constraint was overcome, there appears to be a c-shaped shadow near the distal end, resembling a torn and separated sheath tip.Per the technical summary, the instructions for use (ifu), training manuals and current risk mitigations have been reviewed.No inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.In this case, the torn esheath+ distal tip and separated esheath+ tip were confirmed based on review of the provided imagery.Sheath distal tip tears may result from a combination of multiple contributing factors.The tip expansion mechanism may be influenced by inherent variation in the tip scoring process and/or by other manufacturing-related factors.Additionally, patient or procedural factors, such as challenging anatomy or non-coaxial advancement angles, may exacerbate interference between the valve and distal tip, leading to increased resistance and potential tearing during system advancement.In this case, the patient's access characteristics could not be confirmed.High push forces applied to overcome resistance during system advancement can further contribute to tip tearing.While multiple contributing factors have been identified, a definitive root cause is unable to be determined at this time.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.An investigation has been opened to determine the root cause and implement any necessary corrective actions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS ESHEATH+ INTRODUCER SET
Common Device Name
INTRODUCER, CATHETER
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key24592081
Report Number2015691-2026-13183
Device Sequence Number9440600
Product Code DYB
UDI-Device Identifier00690103215472
UDI-Public(01)00690103215472(17)271105(11)251105
Combination Product (Y/N)N
Initial Reporter StateWI
Initial Reporter CountryUS
PMA/510(K) Number
K200258
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/30/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number916ESPA
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/16/2026
Supplement Date Received by Manufacturer04/27/2026
Initial Report FDA Received Date03/13/2026
Supplement Report FDA Received Date04/30/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured11/05/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexMale
-
-